Summaries & Associations of Study Results
TR-039 Lasiocarpine
Target Organs and Levels of Evidence
NTP Technical Report Number 039
Produced from Chemtrack Database 09/19/01
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
LASIOCARPINE 303-34-4 |
11/28/78 | CARCINOGEN IN RESEARCH, USE IN INDIA TO TREAT SNAKEBITES, AS AN EMETIC, HEPATOTOXIC PYRROLIZIDINE (MERCK 1989) | Dosed-Feed 0,7,15,30 PPM/48 PER GROUP | SRI International |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: POSITIVE | VASCULAR SYSTEM (LIVER): ANGIOSARCOMA | |||
FR: POSITIVE | VASCULAR SYSTEM (LIVER): ANGIOSARCOMA | |||
HEMATOPOIETIC SYSTEM (LYMPHOMA) |
Web page last updated on February 10, 2006